Shilpa Medicare has been granted a patent for a pharmaceutical liposomal composition containing docetaxel, Soya Phosphatidyl Choline, Sodium Cholesteryl Sulfate, Sucrose, and a pH adjusting agent with a pH less than 3.5. The composition is prepared by dispersing Soya Phosphatidyl Choline in a solvent mixture of methanol and tertiary butanol. GlobalData’s report on Shilpa Medicare gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Shilpa Medicare, Nanoparticle drug conjugates was a key innovation area identified from patents. Shilpa Medicare's grant share as of February 2024 was 20%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11857680B2) discloses a pharmaceutical liposomal composition containing docetaxel, Soya Phosphatidyl Choline, Sodium Cholesteryl Sulfate, Sucrose, and a pH adjusting agent. The composition is prepared by dispersing Soya Phosphatidyl Choline in a solvent mixture of methanol and tertiary butanol in a specific ratio. The pH of the liposomal composition is maintained below 3.5, with a specific claim mentioning a pH of about 3. Additionally, the size of the liposomes in the composition is specified to be less than 200 nm, ensuring a certain level of uniformity and consistency in the formulation.
Furthermore, the patent includes variations of the composition, with specific percentages of each component mentioned in different claims. For instance, one claim specifies the composition to contain 0.9% w/w of docetaxel, 32% w/w of Soya Phosphatidyl Choline, 0.5% w/w of Sodium Cholesteryl Sulfate, and 66.5% w/w of Sucrose. Another claim reiterates the components and pH range of the liposomal composition, emphasizing the consistency in the formulation across different claims. Overall, the patent highlights a specific formulation method and composition for a pharmaceutical liposomal product containing docetaxel, with precise details regarding the ingredients, proportions, and preparation process to ensure reproducibility and efficacy in pharmaceutical applications.
To know more about GlobalData’s detailed insights on Shilpa Medicare, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
